Primary central nervous system (CNS) lymphoma in immunocompetent patients

By Plasswilm L.   Herrlinger U.   Korfel A.   Weller M.   Küker W.   Kanz L.   Thiel E.   Bamberg M.  

Annals of Hematology, Vol. 81, Iss. 8, 2002-08 ,pp. : 415-423

Springer Publishing Company

Access to resources Recommend Favorite

Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma

By Fischer Lars   Korfel Agnieszka   Kiewe Philipp   Neumann Martin   Jahnke Kristoph   Thiel Eckhard  

Annals of Hematology, Vol. 88, Iss. 2, 2009-02 ,pp. : 133-139

Springer Publishing Company

Access to resources Recommend Favorite

Histiocytosis disorders in Northeast Egypt: epidemiology and survival studies (a 5-year study)

By Al-Tonbary Youssef A.   Sarhan Mohamed M.   Mansour Ahmed K.   Abdelrazik Nabil M.   El-Ashry Rasha A.  

Hematology, Vol. 14, Iss. 5, 2009-10 ,pp. : 271-276

Maney Publishing

Access to resources Recommend Favorite

Anthracyclinebased induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5fluorouracil and radiation therapy in surgically resected axillary nodepositive breast cancer

By                  

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 473-478

Spandidos Publications

Access to resources Recommend Favorite

Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study

By Wong K.M.   Cheung C.Y.   Chan Y.H.   Chak W.L.   Choi K.S.   Chau K.F.   Li C.S.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1721-1722

Elsevier

Access to resources Recommend Favorite